| resveratrol |
| 501-36-0 |
| trans-resveratrol |
| 3,4',5-Trihydroxystilbene |
| (E)-5-(4-Hydroxystyryl)benzene-1,3-diol |
| 3,5,4'-Trihydroxystilbene |
| (E)-resveratrol |
| Resvida |
| 3,4',5-Stilbenetriol |
| 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol |
| 3,4',5-Trihydroxy-trans-stilbene |
| Biofort |
| Cuspidatin |
| 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol |
| SRT 501 |
| SRT-501 |
| (E)-5-(p-Hydroxystyryl)resorcinol |
| Resveratrol p 5 |
| SRT501 |
| Resveratrol(e)-form |
| 3,5,4'-Trihydroxy-trans-stilbene |
| Melinjo resveratrol 20 |
| CHEBI:45713 |
| Srt 501m |
| trans-3,4',5-trihydroxystilbene |
| 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol |
| NSC 327430 |
| NSC-327430 |
| trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene |
| CCRIS 8952 |
| 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol |
| DTXSID4031980 |
| UNII-Q369O8926L |
| HSDB 7571 |
| Resveratrol (Standard) |
| 5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol |
| Ca 1201 |
| C14H12O3 |
| 1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)- |
| 1,3-Benzenediol, 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]- |
| BIA 6-512 |
| BIA-6-512 |
| NSC327430 |
| CHEMBL165 |
| Q369O8926L |
| (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol |
| MLS000069735 |
| 133294-37-8 |
| DTXCID2011980 |
| CHEBI:27881 |
| trans-3,4',5 - trihydroxystilbene |
| MFCD00133799 |
| SMR000058206 |
| RESVERATROL (MART.) |
| RESVERATROL [MART.] |
| 1,3-Benzenediol, 5-((E)-2-(4-hydroxyphenyl)ethenyl)- |
| Resveratol |
| TRANS-RESVERATROL (USP-RS) |
| TRANS-RESVERATROL [USP-RS] |
| 5-((E)-2-(4-HYDROXYPHENYL)-ETHENYL) BENZENE-1,3 DIOL |
| trans Resveratrol |
| 3,4',5-trihydroxy-stilbene |
| Resveratrol, natural |
| 5-(2-(4-hydroxyphenyl)ethenyl)benzene-1,3-diol |
| SR-01000000163 |
| 5-((E)-2-(4-hydroxyphenyl)vinyl)benzene-1,3-diol |
| 1,3-Benzenediol, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]- |
| Jotrol |
| 3fts |
| 4jaz |
| 4qer |
| Resveratrol, E- |
| Resveratrol,(S) |
| KUC104385N |
| Stilbene, 2f |
| TaxusChinensisiRehd |
| NCGC00015894-02 |
| CAS-501-36-0 |
| STL |
| Prestwick_619 |
| Resveratrol, trans- |
| (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol |
| KSC-10-164 |
| Resveratrol, synthetic |
| RM-1812 |
| Opera_ID_586 |
| RESVERATROL [MI] |
| Prestwick2_000508 |
| Prestwick3_000508 |
| Spectrum5_000552 |
| RESVERATROL [HSDB] |
| RESVERATROL [INCI] |
| R 5010 |
| RESVERATROL [VANDF] |
| 1,3-Benzenediol, 5-[(1Z)-2-(4-hydroxyphenyl)ethenyl]- |
| Lopac0_001111 |
| REGID_for_CID_6240 |
| SCHEMBL19425 |
| BSPBio_000435 |
| BSPBio_001114 |
| BSPBio_003461 |
| RESVERATROL [WHO-DD] |
| MLS001055357 |
| MLS001076538 |
| MLS001424228 |
| MLS002207121 |
| MLS002222231 |
| SPECTRUM1502223 |
| CU-01000001503-3 |
| BPBio1_000479 |
| cid_445154 |
| GTPL8741 |
| SGCUT00007 |
| Resveratrol, analytical standard |
| REGID_for_CID_445154 |
| BDBM23926 |
| Resveratrol, >=99% (HPLC) |
| AMY5760 |
| 2l98 |
| BCPP000091 |
| HMS1362H15 |
| HMS1569F17 |
| HMS1792H15 |
| HMS1921N04 |
| HMS1990H15 |
| HMS2052I09 |
| HMS2096F17 |
| HMS2232A18 |
| HMS3263O04 |
| HMS3403H15 |
| HMS3412O14 |
| HMS3649A20 |
| HMS3676O14 |
| BCP01416 |
| to_000079 |
| Tox21_110257 |
| Tox21_201374 |
| Tox21_303376 |
| Tox21_501111 |
| AC-727 |
| BBL028252 |
| CCG-38874 |
| HB4055 |
| HY-16561R |
| LMPK13090005 |
| s1396 |
| STL146386 |
| AKOS005720936 |
| Tox21_110257_1 |
| CS-1050 |
| DB02709 |
| KS-5047 |
| LP01111 |
| MCULE-5678456463 |
| NC00349 |
| SDCCGMLS-0002998.P003 |
| SDCCGSBI-0051080.P003 |
| IDI1_002152 |
| NCGC00017352-05 |
| NCGC00017352-06 |
| NCGC00017352-07 |
| NCGC00017352-08 |
| NCGC00017352-09 |
| NCGC00017352-10 |
| NCGC00017352-11 |
| NCGC00017352-12 |
| NCGC00017352-13 |
| NCGC00017352-14 |
| NCGC00017352-15 |
| NCGC00017352-16 |
| NCGC00017352-17 |
| NCGC00017352-18 |
| NCGC00017352-19 |
| NCGC00017352-24 |
| NCGC00017352-31 |
| NCGC00017352-37 |
| NCGC00017352-39 |
| NCGC00024003-00 |
| NCGC00024003-04 |
| NCGC00024003-05 |
| NCGC00024003-06 |
| NCGC00024003-07 |
| NCGC00024003-08 |
| NCGC00024003-09 |
| NCGC00024003-10 |
| NCGC00024003-11 |
| NCGC00024003-12 |
| NCGC00024003-13 |
| NCGC00024003-14 |
| NCGC00257465-01 |
| NCGC00258925-01 |
| NCGC00261796-01 |
| 1ST40018 |
| AS-12413 |
| HY-16561 |
| CS-0694771 |
| EU-0101111 |
| R0071 |
| Resveratrol, Vetec(TM) reagent grade, 98% |
| SW196786-4 |
| trans [2,5,4'-trihydroxydiphenyl] ethylene |
| C03582 |
| N88795 |
| 5-[2-(4-hydroxyphenyl)vinyl]-1,3-benzenediol |
| AB00052942-29 |
| AB00052942_31 |
| trans-Resveratrol 100 microg/mL in Acetonitrile |
| A827984 |
| Q407329 |
| 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzoldiol |
| SR-01000000163-3 |
| SR-01000000163-4 |
| SR-01000000163-9 |
| 5-[(E)-2-(4-Hydroxyphenyl)ethenyl]benzol-1,3-diol |
| 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzenediol |
| 5[(E)-2-(4-Hydroxyphenyl)-vinyl]benzene 1,3-diol |
| BRD-K25591257-001-01-2 |
| BRD-K80738081-001-06-2 |
| BRD-K80738081-001-07-0 |
| BRD-K80738081-001-09-6 |
| BRD-K80738081-001-10-4 |
| BRD-K80738081-001-23-7 |
| SR-01000000163-10 |
| SR-01000000163-11 |
| SR-01000000163-16 |
| (E)-1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene |
| (E)1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene |
| 5-((1E)-2-(4-hydroxyphenyl)ethenyl)benzene-1,3-diol |
| Resveratrol, certified reference material, TraceCERT(R) |
| Resveratrol, European Pharmacopoeia (EP) Reference Standard |
| 1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)-ethenyl)-, (E)- |
| 533C1DA0-4104-42B5-9D32-9265F40857E4 |
| trans-Resveratrol, United States Pharmacopeia (USP) Reference Standard |
| (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol |
| 31100-06-8 |
| InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1 |